BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23105127)

  • 21. Overview of human cytochrome P450 networks in chemical space.
    Basith S; Choi S
    Arch Pharm Res; 2010 Sep; 33(9):1289-91. PubMed ID: 20945125
    [No Abstract]   [Full Text] [Related]  

  • 22. Software-aided cytochrome P450 reaction phenotyping and kinetic analysis in early drug discovery.
    Cece-Esencan EN; Fontaine F; Plasencia G; Teppner M; Brink A; Pähler A; Zamora I
    Rapid Commun Mass Spectrom; 2016 Jan; 30(2):301-10. PubMed ID: 26689160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thermophilic cytochrome P450 enzymes.
    Nishida CR; Ortiz de Montellano PR
    Biochem Biophys Res Commun; 2005 Dec; 338(1):437-45. PubMed ID: 16139791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure and chemistry of cytochrome P450.
    Denisov IG; Makris TM; Sligar SG; Schlichting I
    Chem Rev; 2005 Jun; 105(6):2253-77. PubMed ID: 15941214
    [No Abstract]   [Full Text] [Related]  

  • 25. Focus on molecules: cytochrome P450 family 4, subfamily V, polypeptide 2 (CYP4V2).
    Mackay DS; Halford S
    Exp Eye Res; 2012 Sep; 102():111-2. PubMed ID: 21745470
    [No Abstract]   [Full Text] [Related]  

  • 26. Which oxidant is really responsible for sulfur oxidation by cytochrome P450?
    Li C; Zhang L; Zhang C; Hirao H; Wu W; Shaik S
    Angew Chem Int Ed Engl; 2007; 46(43):8168-70. PubMed ID: 17886330
    [No Abstract]   [Full Text] [Related]  

  • 27. Cytochrome P450 flexibility.
    Poulos TL
    Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13121-2. PubMed ID: 14597705
    [No Abstract]   [Full Text] [Related]  

  • 28. Cytochrome p450 conformational diversity.
    Stout CD
    Structure; 2004 Nov; 12(11):1921-2. PubMed ID: 15530355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Mutual Drug-Drug Interaction within Geneva Cocktail for Cytochrome P450 Phenotyping using Innovative Dried Blood Sampling Method.
    Bosilkovska M; Samer C; Déglon J; Thomas A; Walder B; Desmeules J; Daali Y
    Basic Clin Pharmacol Toxicol; 2016 Sep; 119(3):284-90. PubMed ID: 27009433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Foreword.
    Hrycay EG; Bandiera SM
    Adv Exp Med Biol; 2015; 851():v-vii. PubMed ID: 26380853
    [No Abstract]   [Full Text] [Related]  

  • 31. Resonance Raman detection of the hydroperoxo intermediate in the cytochrome P450 enzymatic cycle.
    Mak PJ; Denisov IG; Victoria D; Makris TM; Deng T; Sligar SG; Kincaid JR
    J Am Chem Soc; 2007 May; 129(20):6382-3. PubMed ID: 17461587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of hepatic cirrhosis on the intrinsic clearances of sorafenib and imatinib by CYPs in human liver.
    Murray M; Gillani TB; Ghassabian S; Edwards RJ; Rawling T
    Eur J Pharm Sci; 2018 Mar; 114():55-63. PubMed ID: 29223619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Theoretical perspective on the structure and mechanism of cytochrome P450 enzymes.
    Shaik S; Kumar D; de Visser SP; Altun A; Thiel W
    Chem Rev; 2005 Jun; 105(6):2279-328. PubMed ID: 15941215
    [No Abstract]   [Full Text] [Related]  

  • 34. Consultation-liaison psychiatry drug--drug interactions update.
    Armstrong SC; Cozza KL
    Psychosomatics; 2000; 41(6):541-3. PubMed ID: 11110122
    [No Abstract]   [Full Text] [Related]  

  • 35. Cytochrome P450 monooxygenases: perspectives for synthetic application.
    Urlacher VB; Eiben S
    Trends Biotechnol; 2006 Jul; 24(7):324-30. PubMed ID: 16759725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytochrome p450 in silico: an integrative modeling approach.
    de Graaf C; Vermeulen NP; Feenstra KA
    J Med Chem; 2005 Apr; 48(8):2725-55. PubMed ID: 15828810
    [No Abstract]   [Full Text] [Related]  

  • 37. Laboratory evolution of peroxide-mediated cytochrome P450 hydroxylation. Joo H, Lin Z, Arnold FH. Nature 1999; 399: 670-673.
    Aust SD
    Redox Rep; 1999; 4(5):195-7. PubMed ID: 10731094
    [No Abstract]   [Full Text] [Related]  

  • 38. Is the ferric hydroperoxy species responsible for sulfur oxidation in cytochrome p450s?
    Cryle MJ; De Voss JJ
    Angew Chem Int Ed Engl; 2006 Dec; 45(48):8221-3. PubMed ID: 17111450
    [No Abstract]   [Full Text] [Related]  

  • 39. Enzyme promiscuity: using a P450 enzyme as a carbene transfer catalyst.
    Roiban GD; Reetz MT
    Angew Chem Int Ed Engl; 2013 May; 52(21):5439-40. PubMed ID: 23592495
    [No Abstract]   [Full Text] [Related]  

  • 40. Multiple oxidants and multiple mechanisms in cytochrome P450 catalysis.
    Coon MJ
    Biochem Biophys Res Commun; 2003 Dec; 312(1):163-8. PubMed ID: 14630036
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.